Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F57BL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,910
Award facts
- Contract value 100% obligated
- $36,909.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This order, valued at $36,909.68, represents a firm fixed price delivery against AmerisourceBergen's larger pharmaceutical supply contract with DLA. The award was made on a competitive, non-set-aside basis and is scheduled for completion by January 2, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains an extensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the parent contract vehicle for this delivery order.
The IDC under which this award was issued functions as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. This delivery order for BIKTARVY, an HIV treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare systems. The firm fixed pricing structure and rapid completion timeline reflect the efficient procurement mechanisms established under DLA's pharmaceutical prime vendor program, which maintains multiple contractor relationships to ensure reliable supply chains for critical defense medical operations.
Quick answers
Who was awarded contract SPE2DR26F57BL?
SPE2DR26F57BL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F57BL worth?
The government has obligated $36,910 on SPE2DR26F57BL.
Is contract SPE2DR26F57BL an order under another contract?
Yes. SPE2DR26F57BL is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57BL competed?
The extent of competition for SPE2DR26F57BL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award